We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current REPR market cap is 182.68M. The company's latest EPS is USD -0.3009 and P/E is -13.29.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.76M | 7.35M | 7.39M | 6.94M | 7M |
| Operating Income | -1.53M | -2.51M | -3.06M | -3.22M | -1.79M |
| Net Income | -1.23M | -1.98M | -2.41M | -2.5M | -1.37M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 23.16M | 24.18M | 23.49M | 27.9M | 28.52M |
| Operating Income | 586k | -1.26M | -7.03M | -10.78M | -10.27M |
| Net Income | 564k | -1.21M | -4.56M | -8.66M | -13.74M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 42.67M | 42.33M | 38.25M | 36M | 35.35M |
| Total Liabilities | 10.17M | 11.01M | 8.46M | 7.9M | 7.92M |
| Total Equity | 32.49M | 31.33M | 29.8M | 28.1M | 27.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.88M | 39.92M | 41.29M | 42.33M | 28.46M |
| Total Liabilities | 2.65M | 3.76M | 4.79M | 11.01M | 8.11M |
| Total Equity | 11.24M | 36.16M | 36.5M | 31.33M | 20.35M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.74M | -5.41M | -4.66M | -4.82M | -5.99M |
| Investing | -2.58M | -2.8M | -284k | -392k | -606k |
| Financing | 425k | 280k | -239k | -482k | -41k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 320k | -743k | -4.32M | -5.41M | -4.89M |
| Investing | 1.31M | -1.04M | -366k | -2.8M | -815k |
| Financing | 501k | 23.22M | 2.71M | 280k | -218k |
| Market Cap | 182.68M |
| Price to Earnings Ratio | -13.29 |
| Price to Sales Ratio | 6.41 |
| Price to Cash Ratio | 15.91 |
| Price to Book Ratio | 8.97 |
| Dividend Yield | - |
| Shares Outstanding | 45.67M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.23 (5.62%) |
| Company Name | Repro Med Systems Inc |
| Address |
24 carpenter road rochester, new york 10918 |
| Website | https://www.rmsmedicalproducts.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
